Asthma medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study
Publication date
2015-09-01
Authors
Ahmadizar, Fariba
Maitland - van der Zee, Anke-Hilse
de Boer, Ton
Souverein, Patrick
Arets, Hubertus
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Background: It has been reported that patients with type 1 diabetes (T1DM) have a decreased lung function. Studies on the association of T1DM and asthma in children show controversial results. Objectives: The aim of this study was to quantify asthma medication use in children and adolescents with and without (reference cohort) T1DM 5 years before and after the onset of diabetes. Methods: A population-based cohort study was conducted in the Dutch PHARMO Record Linkage System. All children (
Keywords
insulin, muscarinic receptor blocking agent, adolescent, asthma, child, cohort analysis, controlled study, diabetic patient, follow up, human, incidence, insulin dependent diabetes mellitus, major clinical study, prescription, prevalence, quantitative study, sex ratio, Taverne, SDG 3 - Good Health and Well-being
Citation
Ahmadizar, F, Maitland-Van Der Zee, A-H, De Boer, A, Souverein, P & Arets, H 2015, 'Asthma medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study', Pharmacoepidemiology and Drug Safety, vol. 24, no. S1, pp. 275. https://doi.org/10.1002/pds.3838